120 related articles for article (PubMed ID: 17617654)
1. Angiogenic factors in preeclampsia: so complex, so simple?
Berkane N; Lefevre G; Hertig A
Nephrol Dial Transplant; 2007 Oct; 22(10):2753-6. PubMed ID: 17617654
[No Abstract] [Full Text] [Related]
2. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia.
Seki H
Acta Obstet Gynecol Scand; 2014 Oct; 93(10):959-64. PubMed ID: 25139038
[TBL] [Abstract][Full Text] [Related]
3. Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins.
Huppertz B
Biochim Biophys Acta Mol Basis Dis; 2020 Feb; 1866(2):165349. PubMed ID: 30553017
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenic factors in preeclampsia.
Levine RJ; Karumanchi SA
Clin Obstet Gynecol; 2005 Jun; 48(2):372-86. PubMed ID: 15805796
[No Abstract] [Full Text] [Related]
5. Redefining preeclampsia using placenta-derived biomarkers.
Staff AC; Benton SJ; von Dadelszen P; Roberts JM; Taylor RN; Powers RW; Charnock-Jones DS; Redman CW
Hypertension; 2013 May; 61(5):932-42. PubMed ID: 23460278
[No Abstract] [Full Text] [Related]
6. Expression of genes coding for proangiogenic factors and their receptors in human placenta complicated by preeclampsia and intrauterine growth restriction.
Semczuk M; Borczynska A; Bialas M; Rozwadowska N; Semczuk-Sikora A; Malcher A; Kurpisz M
Reprod Biol; 2013 Jun; 13(2):133-8. PubMed ID: 23719118
[TBL] [Abstract][Full Text] [Related]
7. Preeclampsia: new insights.
Shah DM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications.
Jim B; Karumanchi SA
Semin Nephrol; 2017 Jul; 37(4):386-397. PubMed ID: 28711078
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
Petersen TM; Larsen T; Nielsen HJ
Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
[TBL] [Abstract][Full Text] [Related]
10. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic growth factors and their receptors in first-trimester human decidua of pregnancies further complicated by preeclampsia or fetal growth restriction.
Plaisier M; Streefland E; Koolwijk P; van Hinsbergh VW; Helmerhorst FM; Erwich JJ
Reprod Sci; 2008 Sep; 15(7):720-6. PubMed ID: 18562698
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Preeclampsia.
Hod T; Cerdeira AS; Karumanchi SA
Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26292986
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
15. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
16. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
Lam C; Lim KH; Karumanchi SA
Hypertension; 2005 Nov; 46(5):1077-85. PubMed ID: 16230516
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between fetal growth restriction and angiogenesis factors].
Huang Y; Liu Q; Yu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1068-70. PubMed ID: 25057087
[TBL] [Abstract][Full Text] [Related]
18. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
19. Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery.
Sammar M; Nisemblat S; Fleischfarb Z; Golan A; Sadan O; Meiri H; Huppertz B; Gonen R
Placenta; 2011 Feb; 32 Suppl():S30-6. PubMed ID: 21257080
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
